Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equipotent dose comparison of phenylephrine versus Akrinor for prevention of post-spinal hypotension during Cesarean section
2013-005617-13Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of cafedrine + theodrenaline and phenylephrine in hypotension and Cardiac complications of anesthesia during labor and delivery (2 arms), sponsored by UZ Leuven. Primary endpoint: Equipotent dose of Akrinor versus phenylephrine. Started Feb 2014; status: completed.
02
Drugs
cafedrine + theodrenalinephenylephrine
03
Conditions
hypotensionCardiac complications of anesthesia during labor and delivery
Beyond the preview
Go deeper on 2013-005617-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005617-13.